Avada includes a blog shortcode you can use anywhere on the site!
Approval concerns filgrastim-sndz intended for patients with cancer who receive myelosuppressive chemotherapy
Date: 10 Mar 2015 Topic: Palliative and supportive care On 6 March 2015 the US Food and Drug Administration (FDA) approved filgrastim-sndz (Zarxio), the first biosimilar product approved in the United States. Sandoz Inc.’s Zarxio
Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas
Pancreatic cancer mutational landscape Date: 04 Mar 2015 Topic: Translational research / Gastrointestinal cancers The researchers performed whole-genome sequencing and copy number variation analysis of 100 samples to reveal mutational landscape of pancreatic ductal adenocarcinomas.
New research reveals a connection between ccRCC and exposure to an ingredient in some herbal remedies
Date: 03 Nov 2014 Topic: Genitourinary cancers / Translational research New research by the international Cancer Genomics of the Kidney consortium (CAGEKID) reveals an important connection between clear cell renal cell cancer (ccRCC) and exposure